Nektar Therapeutics (NKTR) EBT Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Nektar Therapeutics | 1.60 Bn | 1.04 Bn | 3.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 18.91% |
| Dec 31, 2025 | 21.59% |
| Sep 30, 2025 | 20.25% |
| Jun 30, 2025 | 13.18% |
| Mar 31, 2025 | 19.65% |
| Dec 31, 2024 | 15.58% |
| Sep 30, 2024 | 17.76% |
| Jun 30, 2024 | 13.84% |
| Mar 31, 2024 | 20.97% |
| Dec 31, 2023 | 16.40% |
| Sep 30, 2023 | 13.91% |
| Jun 30, 2023 | -15.47% |
| Mar 31, 2023 | -7.49% |
| Dec 31, 2022 | -10.94% |
| Sep 30, 2022 | -24.32% |
| Jun 30, 2022 | -21.61% |
| Mar 31, 2022 | -7.21% |
| Dec 31, 2021 | -26.83% |
| Sep 30, 2021 | -24.64% |
| Jun 30, 2021 | -20.89% |
| Mar 31, 2021 | -44.76% |
| Dec 31, 2020 | -16.16% |
| Sep 30, 2020 | -68.01% |
| Jun 30, 2020 | -8.75% |
| Mar 31, 2020 | -43.42% |
| Dec 31, 2019 | -18.04% |
| Sep 30, 2019 | -27.66% |
| Jun 30, 2019 | -27.70% |
| Mar 31, 2019 | -21.03% |
| Dec 31, 2018 | -23.47% |
| Sep 30, 2018 | -42.79% |
| Jun 30, 2018 | 90.25% |
| Mar 31, 2018 | -11.73% |
| Dec 31, 2017 | 9.61% |
| Sep 30, 2017 | 27.80% |
| Jun 30, 2017 | -11.82% |
| Mar 31, 2017 | -9.24% |
| Dec 31, 2016 | 37.20% |
| Sep 30, 2016 | -12.44% |
| Jun 30, 2016 | -5.94% |
| Mar 31, 2016 | 11.64% |
| Dec 31, 2015 | -17.63% |
| Sep 30, 2015 | 0.78% |
| Jun 30, 2015 | -155.09% |
| Mar 31, 2015 | 50.98% |